CSPC PHARMA Receives USD30 million Upfront Payment From AstraZenecaAASTOCKS News·17 hours ago01093+2.02%AZN-0.16%
CSPC Pharmaceutical receives USD 30 million upfront payment from AstraZeneca under siRNA pactPUBT·20 hours ago01093+2.02%AZN-0.16%
Spero Q2 FY26 net loss widens to $9.6 million; revenue posts no revenuePUBT·12 hours agoSPRO-3.25%01801-0.42%
BofAS: China's CXO Sector Benefiting From Strong Biotech Financing, Raises TPs for WUXI APPTEC and OthersAASTOCKS News·1 day ago, 10:36 PMWXXWY-0.34%02359+2.16%
CSPC PHARMA Monkeypox mRNA Vaccine Approved for US Clinical TrialsAASTOCKS News·2 days ago, 09:21 AM01093+2.02%
Daiwa Reaffirms Their Buy Rating on WuXi AppTec Co., Ltd. Class H (2359)Tip Ranks·1 day ago, 07:26 PM02359+2.16%603259+2.07%
CSPC says FDA clears US clinical trial for SYS 6037 mpox mRNA vaccinePUBT·2 days ago, 05:58 AM01093+2.02%
00:05 ETAkeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancerprnewswire·Aug 9 at 11:06 PM09926+1.47%
Innovent Biologics signs exclusive deal with Daiichi Sankyo to commercialize Vanflyta in ChinaPUBT·Aug 9 at 07:00 PM01801-0.42%4568
Sino Biopharma wins China NMPA approval for first-line squamous NSCLC combo therapyPUBT·Aug 7 at 05:58 AM01177-1.12%
Hong Kong stock movement: WUXI BIO rises 10%, acquires Chuangsheng assets to expand capacityHK Stock Alerts·Aug 7 at 02:02 AM02269+0.04%
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for First-Line Treatment of Patients with Squamous Non-Small Cell Lung Cancer | SMMT Stock NewsStockTitan·1 day ago, 12:22 AMSMMT-0.10%09926+1.47%
BOCOM International Holdings Company Sticks to Their Buy Rating for Innovent Biologics (IVBXF)Tip Ranks·Aug 7 at 12:55 AM01801-0.42%
